Bone marrow stromal cells from breast cancer patients also produced sufficient OPG levels to decrease TRAIL sensitivity of breast cancer cells providing a mechanism for the occurrence of metastatic lesions in the bone (67). The gene discussed is TNFSF10; the disease is breast cancer.